Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration

BACKGROUND: Dexlansoprazole is a proton pump inhibitor (PPI) approved for use in dual delayed-release capsule and orally disintegrating tablet (ODT) formulations. AIM: To assess effects of food, water, and route of administration on the bioavailability of dexlansoprazole 30-mg ODT. METHODS: Two sepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kukulka, Michael, Nudurupati, Sai, Perez, Maria Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323062/
https://www.ncbi.nlm.nih.gov/pubmed/28255251
http://dx.doi.org/10.2147/CEG.S121129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323062/
https://www.ncbi.nlm.nih.gov/pubmed/28255251
http://dx.doi.org/10.2147/CEG.S121129

Ejemplares similares